Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Healthcare Insurance topic
No spam. Unsubscribe anytime.
Senate panel advances bill to require insurers cover scalp-cooling during chemotherapy
Summary
The Senate Finance Committee recommended passage of House bill 40 89, which would require West Virginia insurance products, including PEIA and Medicaid, to cover scalp-cooling systems used during chemotherapy for policies renewed or issued on or after July 1, 2027.
The Senate Finance Committee voted by voice to report House bill 40 89 to the full Senate with the recommendation that it pass.
Committee counsel said the bill would require all insurance products offered in West Virginia to cover a scalp cooling system used during chemotherapy treatment. Counsel said the mandate would take effect for policies renewed or issued on or after July 1, 2027, and would apply to commercial insurers as well as PEIA and Medicaid.
Senior senator from the eighth moved the bill be reported to the full Senate; the motion carried by voice vote. No roll-call tally was recorded in the committee transcript.
The committee advanced the measure to the Senate floor for further consideration.
